Show simple item record

dc.creatorGhi, Tullio
dc.creatorPasquo, Elvira di
dc.creatorMekinian, Arsene
dc.creatorCalza, Leonardo
dc.date.accessioned2020-08-06T20:22:16Z
dc.date.available2020-08-06T20:22:16Z
dc.date.created2020
dc.identifier.issn0301-2115spa
dc.identifier.otherhttps://doi.org/10.1016/j.ejogrb.2020.07.025spa
dc.identifier.urihttp://hdl.handle.net/20.500.12010/11707
dc.description.abstractIn December 2019, a novel coronavirus (Sars-CoV-2) was first reported in Wuhan, in the Hubei province of China and was declared pandemic by the World Health Organization (WHO) on March 11, 2020. While data regarding COVID-19 continues to come out improving our understanding of this disease, data specific to pregnancy remains limited and the clinical characteristics of SARS-CoV2 infection in pregnant women are still scarce.spa
dc.format.extent8 páginasspa
dc.format.mimetypeimage/jepgspa
dc.publisherEuropean Journal of Obstetrics & Gynecology and Reproductivespa
dc.sourcereponame:Expeditio Repositorio Institucional UJTLspa
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozanospa
dc.subjectSars-CoV-2spa
dc.subjectPregnancyspa
dc.subjectInflammationspa
dc.subjectImmunologyspa
dc.titleSars-CoV-2 in pregnancy: Why is it better than expected?spa
dc.type.localArtículospa
dc.subject.lembSíndrome respiratorio agudo gravespa
dc.subject.lembCOVID-19spa
dc.subject.lembSARS-CoV-2spa
dc.subject.lembCoronavirusspa
dc.rights.accessrightsinfo:eu-repo/semantics/embargoedAccessspa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersionspa
dc.rights.localAcceso restringidospa
dc.identifier.doihttps://doi.org/10.1016/j.ejogrb.2020.07.025spa


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record